A Study in Healthy Men to Test Whether Rifampicin Influences the Amount of BI 425809 in the Blood

NCT03082183 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Rifampicin
DRUG: BI 425809

Sponsor

Boehringer Ingelheim